Poland's new draft pharmaceutical law addresses exclusivity
This article was originally published in SRA
Executive Summary
Poland’s Ministry of Health has drafted a new pharmaceutical law, which is under public discussion until 18 August1.The most important difference in comparison to an earlier draft2 issued last year is an amendment to the data exclusivity period for innovative human medicinal products.